Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Novikova, Y. Ilkovich, D. Dzadzua, A. Speranskaya, I. Dvorakovskaya, M. Kameneva (St. Petersburg, Russian Federation). Desquamative interstitial pneumonia: Follow-up of 17 patients. Eur Respir J 2013; 42: Suppl. 57, 2375

Member's Comments

No comment yet.

Related content which might interest you: Biopsy documented idiopathic interstitial pneumonias - Analysis of diagnostic yield, survival and mortality over 9 years Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions Year: 2013 BAL findings in desquamative interstitial pneumonia (DIP) and other idiopathic interstitial pneumonia (IIP) Source: International Congress 2014 – ILDs 4 Year: 2014 Recent improvement of survival of acute exacerbation in idiopathic interstitial pneumonias: 10 years experience Source: International Congress 2014 – ILDs 2 Year: 2014 Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome Source: International Congress 2014 – ILDs 2 Year: 2014 The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Pulmonary interstitial glycogenosis: Diagnosis and follow-up Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments Year: 2016 Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015 Long-term treatment with nintedanib in patients with IPF: An update from INPULSIS®-ON Source: International Congress 2016 – IPF treatment II Year: 2016 Evolution of an interstitial lung disease MDT: 5.5 years of data Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Transbronchial cryobiopsy for the diagnosis of interstitial lung disease (ILD) – The UK experience Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Emphysematous changes in chronic hypersensitivity pneumonitis: A retrospective analysis of 12 patients Source: International Congress 2016 – Orphan diseases II Year: 2016 Clues in interstitial lung disease in children (chILD) Source: International Congress 2016 – Paediatric bronchology II Year: 2016 Corticosteroids determine clinical course of IIPs with possible UIP HRCT pattern? Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Lymphopoenia and pneumocystis jiroveci (PCP) prophylaxis experience in non-specific interstitial pneumonitis (NSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Pulmonary thromboembolism (PE) in patients with interstitial lung diseases (ILD) Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Transbronchial cryobiopsy in the diagnosis of the idiopathic interstitial pneumonias Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016 Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema Source: International Congress 2015 – IPF: clinical aspects Year: 2015